Skip to main content

STERIS Value Stock - Dividend - Research Selection

Steris

ISIN: IE00BFY8C754 , WKN: A2PGLV

Market price date:
Market price:  


Fundamental data and company key figures of the share

Annual reports in
Key figures
Cash flow
Net operating cash flow
Capital Expenditures
Free cash flow
Balance sheet
Total Equity
Liabilities & Shareholders equity
Income statement
Net income
Eps (diluted)
Diluted shares outstanding
Net sales/revenue

Fundamental ratios calculated on:

Ratios
Key figures
Cash flow
P/C
 
P/FC
Balance sheet
ROI
ROE
Income statement
P/E
Div. Yield %
P/B
P/S


Do you want to do make a detailed fundamental analysis of this stock?

✓ NEW Fundamental API Access to 500 data points per month
Fundamental data up to 25 years
Comparison to all other stocks by the FScore
Time saving!

How our site works ...

Non-binding 7 days without automatic subscription
 No termination required after the free week
Finanzoo fundamental analysis
Data updated daily
Virtual depots
Share alarms via email
Subscription can be canceled at any time at the end of the month 
Choice of desired shares
Over 2000 stock analyzes available
Bitcoin payment possible if you do not want to subscribe

Price for monthly subscription $ 19.99 / month including VAT.



Description Data
Symbol
Market Capitalization USD
Country
Indices
Sectors
Raw Data Source
Stock Split
Internet


Description of the company

STERIS plc provides infection prevention and other procedural products and services worldwide. It operates in four segments: Healthcare Products, Healthcare Specialty Services, Life Sciences, and Applied Sterilization Technologies. The Healthcare Products segment offers cleaning chemistries and sterility assurance products; accessories for gastrointestinal (GI) procedures, washers, sterilizers, and other pieces of capital equipment for the operation of a sterile processing department; and equipment used directly in the operating room, including surgical tables, lights, equipment management services, and connectivity solutions. It also provides capital equipment installation, maintenance, upgradation, repair, and troubleshooting services. This segment offers its products and services to acute care hospitals, ambulatory surgery centers, and GI clinics. The Healthcare Specialty Services segment provides solutions and managed services, such as instrument and endoscope repair and maintenance solutions; custom process improvement consulting services; and outsourced instrument sterile processing services to acute care hospitals and other healthcare settings. The Life Sciences segment offers formulated cleaning chemistries, barrier and sterility assurance products, steam and vaporized hydrogen peroxide sterilizers, and washer disinfectors. The Applied Sterilization Technologies segment provides contract sterilization and testing services for medical device and pharmaceutical manufacturers through a network of approximately 50 contract sterilization and laboratory facilities. The company was founded in 1985 and is based in Dublin, Ireland.

The Finanzoo GmbH assumes no liability for the accuracy of the information! All information is provided without warranty. Sources:: www.bundesanzeiger.de, www.sec.gov,


NEWS


3 Low-Volatility Stocks That Concern Us

2025-12-16
Low-volatility stocks may offer stability, but that often comes at the cost of slower growth and the upside potential of more dynamic companies.

Dividend Champion, Contender, And Challenger Highlights: Week Of December 14

2025-12-12
Read the latest list of Dividend Champions, Contenders, and Challengers. Track changes, upcoming ex-dividend and pay dates here.

Is STERIS Stock Outperforming the S&P 500?

2025-12-10
STERIS has outperformed the S&P 500 over the past year, and analysts are cautiously optimistic about the stock’s prospects.

These 3 Stocks Are Healthcare Leaders. Bullish Charts Show It.

2025-12-09
Several non-biotech healthcare stocks are starting to show real momentum, breaking out of bases and asserting themselves as leaders in the sector. With improving volume patterns, accelerating relative strength, and clean technical setups, this group of medical technology, services, and equipment stocks is quickly becoming one of the strongest pockets in the market. As buyers rotate toward areas showing sustained upside follow-through, these healthcare names look poised to extend their momentum and deliver standout performance in the weeks ahead.

Has STERIS' 30% 2025 Rally Left Much Value on the Table?

2025-12-07
Wondering if STERIS is still worth buying at today’s price, or if most of the upside has already been captured? This breakdown will help you decide whether the current market tag makes sense. Despite a small pullback of 1.1% over the last week and a flat 30 day move, the stock is still up 30.0% year to date and 23.2% over the last year, suggesting that investors have been steadily repricing its prospects. That rerating has been underpinned by a steady stream of positive updates around...

Why Is Steris (STE) Up 0.4% Since Last Earnings Report?

2025-12-05
Steris (STE) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

Should You Hold STERIS Stock in Your Portfolio for Now?

2025-12-04
STE posts solid AST and Healthcare growth, but currency swings and macro pressures pose rising challenges.

3 Unpopular Stocks with Warning Signs

2025-12-04
When Wall Street turns bearish on a stock, it’s worth paying attention. These calls stand out because analysts rarely issue grim ratings on companies for fear their firms will lose out in other business lines such as M&A advisory.

1 Reason to Avoid STE and 1 Stock to Buy Instead

2025-12-04
Although STERIS (currently trading at $259.38 per share) has gained 7.1% over the last six months, it has trailed the S&P 500’s 14.4% return during that period. This may have investors wondering how to approach the situation.

Steris PLC stock underperforms Tuesday when compared to competitors

2025-12-02
Steris PLC stock underperforms Tuesday when compared to competitors